The current level reflects a downward revision of 0.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period. In its upcoming report, Stryker (SYK) is predicted by Wall Street analysts to post quarterly earnings of $2.73 per share, reflecting an increase of 9.2% compared to the same period last year. Revenues are forecasted to be $5.7 billion, representing a year-over ...

Portage, Michigan, April 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that it will report financial results for its first quarter of fiscal year 2025 on Thursday, May 1, 2025.  A press release will be issued at approximately 4:05 p.m. ET and available at Stryker - Press Releases that day. The press release will include summary financial information for the company's first quarter that ended March 31, 2025. Stryker will host a webcast at 4:30 p.m. ET on Thursday, May 1, 2025, to discuss its firs ...

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE:SYK). The business will operate as a standalone company under the nam ...

VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE: SYK). The business will operate as a standalone company under the na ...

Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC. Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve ...

Portage, Michigan, March 26, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its board of directors has nominated Emmanuel “Manny” Maceda for election to the company’s board at the 2025 Annual Meeting of Shareholders, scheduled for May 8, 2025. Manny brings more than 30 years of experience leading high-performing organizations and advising senior executives on large-scale corporate transformations. He currently serves as Chairman of Bain & Company, following his tenure as Worldwide Managing Partn ...

Portage, Michigan, March 25, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2025 Annual Meeting of Shareholders is scheduled as follows: Thursday, May 8, 2025 – 9:30 a.m. Eastern Time The Meeting will be held virtually via the internet. Information about the webcast, which will include both the audio and the slide presentation from the meeting, is available on the Investor Relations page of our website at www.investorevents.stryker.com. To listen to the meeting as a guest dial (877) 328-2502 (U. ...

Latest technology offers more applications and innovation across more specialtiesMAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE: SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics ...

Core Insights - Inari Medical, now part of Stryker, has launched the Artix Thrombectomy System, designed specifically for the peripheral arterial system, aiming to set a new standard for arterial thrombectomy [1][2][4] Product Overview - The Artix Thrombectomy System combines aspiration and mechanical thrombectomy, providing procedural control and versatility for treating arterial blood clots [1][2] - It is Inari's first product targeting the arterial space, building on the success of its venous thrombectomy devices [2][4] Clinical Significance - The system addresses a critical clinical need for effective treatment of chronic thrombi and aims to reduce the risk of clot migration [4] - Dr. Jonathan Bowman, who performed the first commercial case, highlighted its effectiveness in managing a wide range of clots while maintaining vessel access [3][4] Key Features - The Artix system includes a dual mechanical thrombectomy and aspiration toolkit, designed to remove acute to chronic clots in a single session [7] - It features an 8 Fr. low profile, trackable, kink-resistant sheath available in 65cm and 90cm lengths, enhancing treatment options for complex interventions [7] - The innovative over-the-wire mechanical element is designed to effectively collect and retrieve clots, while a covered nitinol mesh funnel minimizes the risk of arterial clot migration during procedures [7][9] Company Background - Stryker, a global leader in medical technologies, acquired Inari Medical on February 19, 2025, to enhance its portfolio in treating venous and arterial diseases [5][4] - Stryker impacts over 150 million patients annually through its innovative products and services across various medical fields [4]

Core Insights - Stryker has launched the Steri-Shield 8 personal protection system, enhancing its leadership in medical technologies and personal protective equipment [1][2] - The launch aligns with Stryker's strategy of continuous innovation and complements its existing product portfolio [1][2] Product Features and Benefits - Steri-Shield 8 features a customizable helmet with a secure fit and a ponytail path for long-haired users, enhancing comfort and usability [4] - The helmet offers a 22% wider field of vision and improved lighting compared to previous versions, along with a targeted cooling system for user comfort [4][5] - The system includes AAMI Level 4 protection, providing the highest fluid and microbial barrier for healthcare professionals [5] Market Performance - Stryker's shares declined by 1.3% following the launch, influenced by broader market weakness, while the company’s shares have increased by 6.6% year-to-date, outperforming the industry [3] - The S&P 500 Index has seen a decline of 0.9% during the same period [3] Financial Performance - In Q4 2024, Stryker reported revenues of $6.44 billion, a 10.7% year-over-year increase, with an adjusted EPS of $4.01, exceeding market expectations [9] - The company achieved organic sales growth of 10.2%, particularly strong in Instruments, Endoscopy, and Trauma & Extremities segments [9] Strategic Focus - Stryker's recent divestiture of its Spinal Implants business allows for a focus on high-growth areas such as interventional spine and enabling technologies [10] - The acquisition of Inari Medical signifies Stryker's commitment to expanding into high-potential medical markets [10] Complementary Innovations - The Steri-Shield 8 launch complements Stryker's existing MedSurg and Neurotechnology segments, particularly in Instruments and Endoscopy, which have shown strong performance [6] - Recent innovations like the Pangia plating system and LIFEPAK 35 defibrillator have also driven market interest, supporting Stryker's focus on safety and efficiency [8]